Test That Helps With HIV Treatment Selection Gets FDA Clearance
The test may help clinicians tailor HIV therapy for their patients.
The test may help clinicians tailor HIV therapy for their patients.
Age, racial/ethnic, and risk category disparities exist among patients who discontinue preexposure prophylaxis treatment after initiation.
A recent study supports the efficacy of interprofessional collaboration in linking patients with HIV to care services.
Researchers sought to assess the acceptance of opt-out HIV screening in outpatient settings in the United States.
Researchers examined the prevalence of HIV drug resistance patterns among HIV-infected infants using 3 nationally representative surveys in South Africa that evaluated the effectiveness of national programs to prevent mother-to-child transmission of HIV.
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.
Researchers sought to evaluate differences for missed-visit compared to kept-visit measures among different subgroups of people living with HIV.
Investigators analyzed the relationship between HIV, hepatitis C virus, and peripheral artery disease in women.
In women with HIV and diabetes mellitus, CD4+ lymphocytes may contribute to the development of diabetes mellitus.
Immune reconstitution inflammatory syndrome occurs commonly in infants and young children with HIV initiating ART in countries with a high prevalence of HIV and TB.